2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Schneid Yair | 10% Owner | 10,823,610 | May 1, 2024 |
| Soffer Rochel | — | 5,928,137 | May 16, 2024 |
| ALPHA PHARMA Investments LLC | — | 5,928,137 | May 16, 2024 |
| Novo A/S | 10% Owner | 2,459,021 | Feb 19, 2021 |
| Chang Nancy T | Director | 1,841,920 | Jan 2, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Nov 24, 2025 | Sorensen Mel | CEO | Sell | 27.5 | -70,000 | -26.41% | ✗ | $1.4K |
| May 1, 2025 | May 5, 2025 | Sussman Joel F. | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 1, 2025 | May 5, 2025 | Sorensen Mel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 24, 2025 | Feb 26, 2025 | LOKAY KEVIN G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 24, 2025 | Feb 26, 2025 | FRIEDMAN MICHAEL R. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 24, 2025 | Feb 26, 2025 | CHANG NANCY T | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 24, 2025 | Feb 26, 2025 | Alleva Lawrence M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 30, 2024 | Jan 2, 2025 | CHANG NANCY T | Director | Buy | 97.5 | +7,644,932 | 100.00% | ✗ | $500K |
| Jan 2, 2025 | CHANG NANCY T | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 30, 2024 | Jan 2, 2025 | FRIEDMAN MICHAEL R. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | FRIEDMAN MICHAEL R. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 16, 2024 | Aug 20, 2024 | Sorensen Mel | CEO | Sell | 27.5 | -67,015 | -20.18% | ✗ | $4.8K |
| May 16, 2024 | Soffer Rochel | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 17, 2014 | May 1, 2024 | Schneid Yair | 10% Owner | Buy | 97.5 | +2,780,407 | 34.57% | ✗ | $590.4K |
| Jan 11, 2024 | Apr 1, 2024 | Altamont Pharmaceutical Holdings, LLC | 10% Owner | Sell | 20.0 | -4,200,000 | -79.55% | ✗ | $811.8K |
| Jan 29, 2024 | Feb 26, 2024 | Schneid Yair | 10% Owner | Buy | 95.0 | +932,402 | 13.11% | ✗ | $166.4K |
| Jan 16, 2024 | Schneid Yair | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 13, 2023 | Altamont Pharmaceutical Holdings, LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 1, 2023 | Jul 5, 2023 | Alleva Lawrence M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2023 | Jul 5, 2023 | West Linda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2023 | Jun 16, 2023 | POWELL MICHAEL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2023 | Jun 16, 2023 | West Linda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2023 | Jun 16, 2023 | LOKAY KEVIN G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2023 | Jun 16, 2023 | Cunningham Emmett | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2023 | Jun 16, 2023 | Alleva Lawrence M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 16, 2023 | Mar 20, 2023 | Bachleda Mark | Chief Commercial Officer | Buy | 91.3 | +11,000 | 100.00% | ✗ | $24.7K |
| Mar 10, 2023 | Mar 14, 2023 | Sorensen Mel | CEO | Buy | 95.0 | +100,000 | 43.10% | ✗ | $168.1K |
| Mar 13, 2023 | Mar 14, 2023 | Degnan Chris | CFO | Buy | 91.3 | +10,000 | 100.00% | ✗ | $19.6K |
| Feb 25, 2023 | Feb 28, 2023 | Beardsley Robert A | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2023 | Feb 28, 2023 | Sorensen Mel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2023 | Feb 28, 2023 | Degnan Chris | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2023 | Feb 28, 2023 | Kennedy Eugene P. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2023 | Feb 28, 2023 | Bachleda Mark | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 25, 2023 | Feb 28, 2023 | Stacey Jennifer Evans | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2022 | Nov 22, 2022 | Beardsley Robert A | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 12, 2022 | Sep 13, 2022 | Beardsley Robert A | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 1, 2022 | Sep 2, 2022 | Kennedy Eugene P. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 2, 2022 | Kennedy Eugene P. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 18, 2022 | Jul 20, 2022 | Alleva Lawrence M | Director | Neutral | 27.5 | -4,000 | -27.84% | ✗ | - |
| Jul 1, 2022 | Jul 5, 2022 | West Linda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2022 | Jun 16, 2022 | LOKAY KEVIN G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2022 | Jun 16, 2022 | Alleva Lawrence M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2022 | Jun 16, 2022 | West Linda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2022 | Jun 16, 2022 | POWELL MICHAEL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2022 | Jun 16, 2022 | Cunningham Emmett | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 28, 2022 | Mar 2, 2022 | Beardsley Robert A | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 28, 2022 | Mar 2, 2022 | Stacey Jennifer Evans | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 28, 2022 | Mar 2, 2022 | Degnan Chris | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 28, 2022 | Mar 2, 2022 | HOLMLUND JON T | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 28, 2022 | Mar 2, 2022 | Bachleda Mark | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 28, 2022 | Mar 2, 2022 | Sorensen Mel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 17, 2021 | Dec 20, 2021 | West Linda | Director | Buy | 95.0 | +20,000 | 50.00% | ✗ | $54.8K |
| Dec 17, 2021 | Dec 20, 2021 | Beardsley Robert A | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2021 | Oct 12, 2021 | Bachleda Mark | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2021 | Oct 12, 2021 | Stacey Jennifer Evans | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 12, 2021 | Bachleda Mark | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 12, 2021 | Stacey Jennifer Evans | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 1, 2021 | Sep 3, 2021 | HOLMLUND JON T | Chief Medical Officer | Sell | 7.5 | -47,756 | -100.00% | ✓ | $404.5K |
| Jul 1, 2021 | Jul 6, 2021 | West Linda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Cunningham Emmett | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Alleva Lawrence M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 16, 2021 | Jun 17, 2021 | LOKAY KEVIN G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 16, 2021 | Jun 17, 2021 | Alleva Lawrence M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2021 | Jun 17, 2021 | West Linda | Director | Buy | 95.0 | +10,000 | 33.33% | ✗ | $91.3K |
| Jun 16, 2021 | Jun 17, 2021 | POWELL MICHAEL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 16, 2021 | Jun 17, 2021 | Cunningham Emmett | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 4, 2021 | West Linda | Director | Buy | 95.0 | +10,000 | 50.00% | ✗ | $86.5K |
| Jun 1, 2021 | Jun 3, 2021 | Alleva Lawrence M | Director | Buy | 91.3 | +4,045 | 63.95% | ✗ | $34.7K |
| May 28, 2021 | Jun 2, 2021 | West Linda | Director | Buy | 95.0 | +20,000 | 100.00% | ✗ | $172.8K |
| Mar 26, 2021 | Mar 30, 2021 | Sorensen Mel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2021 | Feb 19, 2021 | Novo Holdings A/S | 10% Owner | Sell | 16.3 | -500,000 | -16.90% | ✗ | $5.3M |
| Jan 26, 2021 | Jan 28, 2021 | Degnan Chris | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2021 | Jan 28, 2021 | Sussman Joel F. | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2021 | Jan 28, 2021 | HOLMLUND JON T | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2021 | Jan 28, 2021 | Beardsley Robert A | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2021 | Jan 28, 2021 | Sorensen Mel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2021 | Jan 28, 2021 | Fratamico Arthur | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 13, 2020 | Nov 17, 2020 | Alleva Lawrence M | Director | Buy | 91.3 | +2,325 | 58.13% | ✗ | $23.8K |
| Nov 12, 2020 | Nov 16, 2020 | Sussman Joel F. | Chief Accounting Officer | Sell | 22.5 | -20,000 | -100.00% | ✗ | $203.8K |
| Oct 26, 2020 | Oct 28, 2020 | HOLMLUND JON T | Chief Medical Officer | Sell | 13.8 | -2,244 | -100.00% | ✓ | $33.7K |
| Oct 15, 2020 | Oct 19, 2020 | Novo Holdings A/S | 10% Owner | Sell | 17.5 | -450,000 | -13.20% | ✗ | $5M |
| Oct 5, 2020 | Oct 7, 2020 | HOLMLUND JON T | Chief Medical Officer | Sell | 10.0 | -10,636 | -100.00% | ✓ | $127.6K |
| Jun 9, 2020 | Jun 10, 2020 | Cunningham Emmett | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2020 | Jun 10, 2020 | POWELL MICHAEL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2020 | Jun 10, 2020 | Alleva Lawrence M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2020 | Jun 10, 2020 | LOKAY KEVIN G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 26, 2020 | May 28, 2020 | HOLMLUND JON T | Chief Medical Officer | Sell | 15.0 | -692 | -100.00% | ✓ | $8.3K |
| May 20, 2020 | May 22, 2020 | HOLMLUND JON T | Chief Medical Officer | Sell | 13.8 | -2,143 | -100.00% | ✓ | $25.7K |
| May 8, 2020 | May 12, 2020 | HOLMLUND JON T | Chief Medical Officer | Sell | 10.0 | -5,958 | -100.00% | ✓ | $71.5K |
| May 5, 2020 | May 7, 2020 | HOLMLUND JON T | Chief Medical Officer | Sell | 10.0 | -6,612 | -100.00% | ✓ | $79.8K |
| Mar 31, 2020 | Apr 2, 2020 | West Linda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 2, 2020 | West Linda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 31, 2020 | Feb 4, 2020 | HOLMLUND JON T | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2020 | Feb 4, 2020 | Sussman Joel F. | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2020 | Feb 4, 2020 | Fratamico Arthur | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2020 | Feb 4, 2020 | Degnan Chris | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2020 | Feb 4, 2020 | Sorensen Mel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2020 | Feb 4, 2020 | Riley Dennis | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2020 | Feb 4, 2020 | Beardsley Robert A | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 13, 2019 | Dec 17, 2019 | Alleva Lawrence M | Director | Buy | 91.3 | +4,000 | 100.00% | ✗ | $39.1K |